Bioprinted Human Lung Cancer-Mimics for Tissue Diagnostics Applications
Tissue Engineering Part A · 01.06.2024 · 30 (11-12) · 270-279
DOI: 10.1089/ten.tea.2023.0149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue Engineering Part A, erschienen am 01.06.2024. Verfasst von Mian Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Bioprinting, Printing, Three-Dimensional. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Developing a reproducible and secure supply of customizable control tissues that standardizes for the cell type, tissue architecture, and preanalytics of interest for usage in applications including diagnostic, prognostic, and predictive assays, is critical for improving our patient care and welfare. The conventionally adopted control tissues directly obtained from patients are not ideal because they oftentimes have different amounts of normal and neoplastic elements, differing cellularity, differing architecture, and unknown preanalytics, in addition to the limited supply availability and thus associated high costs. In this study, we demonstrated a strategy to stably produce tissue-mimics for diagnostics purposes by taking advantage of the three-dimensional (3D) bioprinting technology. Specifically, we take anaplastic lymphoma kinase-positive (Alk+) lung cancer as an example, where a micropore-forming bioink laden with tumor cells was combined with digital light processing-based bioprinting for developing native-like Alk+ lung cancer tissue-mimics with both structural and functional relevancy. It is anticipated that our proposed methodology will pave new avenues for both fields of tissue diagnostics and 3D bioprinting significantly expanding their capacities, scope, and sustainability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, Massachusetts, USA.
- Roche Diagnostics Solutions, Tucson, Arizona, USA.
Zitieren
APA
Wang, M., Li, W., Sanchez Flores, R., Cai, L., Garciamendez-Mijares, C. E., Gill, S., Snyder, D., Millabas, J., Chafin, D., Zhang, Y. S., & Djalilvand, A. (2024). Bioprinted Human Lung Cancer-Mimics for Tissue Diagnostics Applications. Tissue Engineering Part A, 30(11-12), 270-279. https://doi.org/10.1089/ten.tea.2023.0149
Vancouver
Wang M, Li W, Sanchez Flores R, Cai L, Garciamendez-Mijares CE, Gill S, et al. Bioprinted Human Lung Cancer-Mimics for Tissue Diagnostics Applications. Tissue Engineering Part A. 2024;30(11-12):270-279. doi:10.1089/ten.tea.2023.0149
BibTeX
@article{Wang2024,
author = {Wang, Mian and Li, Wanlu and Sanchez Flores, Regina and Cai, Ling and Garciamendez-Mijares, Carlos Ezio and Gill, Scott and Snyder, David and Millabas, Jasmine and Chafin, David and Zhang, Yu Shrike and Djalilvand, Azita},
title = {Bioprinted Human Lung Cancer-Mimics for Tissue Diagnostics Applications},
journal = {Tissue Engineering Part A},
year = {2024},
volume = {30},
number = {11-12},
pages = {270--279},
doi = {10.1089/ten.tea.2023.0149}
}
EUVIMED